Fundz

Borealis Biosciences raised $30 million in an extension of their Series A led by Westlake BioPartners to advance RNA therapeutics for kidney diseases.

Dec 19, 2024

Amount Raised

$30 Million

Round Type

Series A

VancouverBiotechnologyHealth CareTherapeutics

Investors

Novartis AGVersant VenturesWestlake BioPartners

Description

Borealis Biosciences announced a $30 million infusion from an extension of their Series A financing. This expansion brings their total Series A capital to $180 million, aimed at enhancing their RNA therapeutic programs.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Borealis Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Commit Biologics raised $5.7M (Seed) on February 1, 2025.
  • Diag-Nose.io raised $2M (Seed) on January 30, 2025.
  • Atalanta Therapeutics raised $97M (Series B) on January 28, 2025.
  • NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
  • Dermata Therapeutics raised $2.5M (Seed) on January 21, 2025.
  • Phio Pharmaceuticals raised $153K (Seed) on January 17, 2025.

Who to call at Borealis Biosciences, and when

A new round usually means Borealis Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Borealis Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Borealis Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Borealis Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Borealis Biosciences

Location

Vancouver, British Columbia, Canada

About

Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Borealis Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Borealis Biosciences's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Borealis Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.